You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-PRKAG2 (PRKAG2) Antibodies

Full name:
anti-Protein Kinase, AMP-Activated, gamma 2 Non-Catalytic Subunit Antibodies (PRKAG2)
On www.antibodies-online.com are 30 Protein Kinase, AMP-Activated, gamma 2 Non-Catalytic Subunit (PRKAG2) Antibodies from 9 different suppliers available. Additionally we are shipping PRKAG2 Proteins (5) and many more products for this protein. A total of 39 PRKAG2 products are currently listed.
Synonyms:
2410051C13Rik, AAKG, AAKG2, AI854673, CMH6, H91620p, MGC82938, PRKAG2, si:ch211-230l11.1, si:dkey-217f4.2, WPWS
list all antibodies Gene Name GeneID UniProt
PRKAG2 373545  
PRKAG2 51422 Q9UGJ0
PRKAG2 108099 Q91WG5

Show all species

Show all synonyms

All available anti-PRKAG2 Antibodies

Go to our pre-filtered search.

Top referenced anti-PRKAG2 Antibodies

  1. Human Polyclonal PRKAG2 Primary Antibody for IF, IHC - ABIN1534170 : Lang, Yu, Tu, Jiang, Chen, Xin, Liu, Zhao: Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36. in Genomics 2001 (PubMed)

More Antibodies against PRKAG2 Interaction Partners

Cow (Bovine) Protein Kinase, AMP-Activated, gamma 2 Non-Catalytic Subunit (PRKAG2) interaction partners

  1. the PRKAG2 gene can be used for marker-assisted selection to improve the body measurement and meat quality traits in the Qinchuan cattle population.

  2. No differences in PRKAG2 transcript abundance were detected in small intestine, liver or muscle. Correlation between gene expression level of PRKAG2 in rumen and average daily feed intake was detected in both seasons but the direction differed by season.

Horse (Equine) Protein Kinase, AMP-Activated, gamma 2 Non-Catalytic Subunit (PRKAG2) interaction partners

  1. Alleles of 2 equine AMPK (show PRKAA1 Antibodies) gamma subunit genes had no causative role in polysaccharide storage myopathy in horses

Human Protein Kinase, AMP-Activated, gamma 2 Non-Catalytic Subunit (PRKAG2) interaction partners

  1. PRKAG2 cardiac syndrome may present with eccentric distribution of LVH, involving focal mid-infero-lateral pattern in the early disease stage, and more diffuse pattern but focusing on interventricular septum in advanced cases.

  2. Overexpression of G100S mutation in PRKAG2 causes Wolff-Parkinson-White syndrome in transgenic zebrafish.

  3. Its mutation causes AMPK (show PRKAA1 Antibodies) signaling abnormality which leads to cardiac syndrome.

  4. The PRKAG2 autosomal dominant cardiac syndrome may be commonly characterized by Left Ventricular Hypertrophy, an accessory pathway, and progression to conduction disease requiring implantation of a pacemaker.

  5. Data indicate that except AMPK (show PRKAA1 Antibodies)-alpha1, expressions of the other five AMPK (show PRKAA1 Antibodies) subunits -alpha2, -beta1, -beta2, -gamma1 and -gamma2 are significantly higher in ovarian carcinomas.

  6. Single nucleotide polymorphisms in PRKAG2 is associated with drug response in breast cancer.

  7. The authors found that the gene encoding the gamma2 subunit of AMP-activated protein kinase (AMPK (show PRKAA2 Antibodies)) strongly correlated with Zaire Ebolavirus transduction in the tumor cell panel.

  8. The mutation in the PRKAG2 gene was identified as responsible for the familial form of WPW syndrome in this Chinese family.

  9. These two individuals may be considered to suffer from a combination of both a classical hypertrophic cardiomyopathy (due to the two mutations in MYBPC3 (show MYBPC3 Antibodies)) and a glycogen (show GYS1 Antibodies) storage cardiomyopathy (due to the mutation in PRKAG2).

  10. no mutations were detected within the coding region of PRKAG2 in Wolff-Parkinson-White syndrome patients

Mouse (Murine) Protein Kinase, AMP-Activated, gamma 2 Non-Catalytic Subunit (PRKAG2) interaction partners

  1. Prkag2 point mutation causes glycogen (show GYS1 Antibodies) storage via enhanced insulin (show INS Antibodies) sensitivity and AKT (show AKT1 Antibodies) activation. It stimulates postnatal cardiomyocyte proliferation by downregulating FoxO (show FOXO3 Antibodies). It promotes cardiac hypertrophy via mTOR (show FRAP1 Antibodies) activation in developed hearts.

  2. We have demonstrated that a third AMPK gamma2 variant, gamma2-3B, is increasingly expressed in the developing heart.

  3. important for cigarette smoking-induced IL-8 (show IL8 Antibodies) production by lung epithelial cells

  4. CNTF (show CNTF Antibodies)(Ax15) bypasses diet-induced leptin (show LEP Antibodies) resistance to reduce hypothalamic AMPK (show PRKAA1 Antibodies) activity

  5. CR resulted in incerasd AMPK (show PRKAA1 Antibodies) phosphorylation and, hence, activation. GHR (show GHR Antibodies) knockout animals also exhibited invrease p-AMPK (show PRKAA1 Antibodies) levels. P-AMPK (show PRKAA1 Antibodies) levels were not altered by disruption of the GHR (show GHR Antibodies) gene.

  6. Despite high glycogen (show GYS1 Antibodies) content, the TGT400N heart is not protected against ischemia-reperfusion injury.

  7. Ceramide- and AMPK (show PRKAA1 Antibodies)-mediated signaling pathways augment the expression and activity of 11beta-HSD1 (show HSD11B1 Antibodies) in preadipocytes by way of C/EBPbeta (show CEBPB Antibodies).

PRKAG2 Antigen Profile

Antigen Summary

AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family and encodes a protein with four cystathionine beta-synthase domains. Mutations in this gene have been associated with ventricular pre-excitation (Wolff-Parkinson-White syndrome), progressive conduction system disease and cardiac hypertrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

Alternative names and synonyms associated with PRKAG2

  • protein kinase, AMP-activated, gamma 2 non-catalytic subunit (Prkag2) antibody
  • protein kinase, AMP-activated, gamma 2 non-catalytic subunit (PRKAG2) antibody
  • protein kinase, AMP-activated, gamma 2 non-catalytic subunit (prkag2) antibody
  • 2410051C13Rik antibody
  • AAKG antibody
  • AAKG2 antibody
  • AI854673 antibody
  • CMH6 antibody
  • H91620p antibody
  • MGC82938 antibody
  • PRKAG2 antibody
  • si:ch211-230l11.1 antibody
  • si:dkey-217f4.2 antibody
  • WPWS antibody

Protein level used designations for PRKAG2

5'-AMP-activated protein kinase subunit gamma-2 , AMP-activated protein kinase gamma2 subunit , AMPK gamma 2 , adenosine monophosphate-activated protein kinase gamma 2-subunit , 5'-AMP-activated protein kinase gamma-2 non-catalytic subunit , protein kinase, AMP-activated, gamma 2 non-catalytic subunit , AMPK-activated protein kinase gamma-2 subunit , AMPK subunit gamma-2 , 5-AMP-activated protein kinase, gamma-2 subunit , AMPK gamma-2 chain , AMPK gamma2

GENE ID SPECIES
373545 Rattus norvegicus
420435 Gallus gallus
444397 Xenopus laevis
504219 Bos taurus
568316 Danio rerio
100034098 Equus caballus
100125135 Xenopus (Silurana) tropicalis
51422 Homo sapiens
108099 Mus musculus
100173926 Pongo abelii
Selected quality suppliers for anti-PRKAG2 (PRKAG2) Antibodies
Did you look for something else?